IL86423A0 - Pharmaceutical compositions for the treatment of alzheimer's disease - Google Patents
Pharmaceutical compositions for the treatment of alzheimer's diseaseInfo
- Publication number
- IL86423A0 IL86423A0 IL86423A IL8642388A IL86423A0 IL 86423 A0 IL86423 A0 IL 86423A0 IL 86423 A IL86423 A IL 86423A IL 8642388 A IL8642388 A IL 8642388A IL 86423 A0 IL86423 A0 IL 86423A0
- Authority
- IL
- Israel
- Prior art keywords
- alzheimer
- disease
- treatment
- pharmaceutical compositions
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5189787A | 1987-05-19 | 1987-05-19 | |
| US18800588A | 1988-05-11 | 1988-05-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL86423A0 true IL86423A0 (en) | 1988-11-15 |
Family
ID=26729929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL86423A IL86423A0 (en) | 1987-05-19 | 1988-05-18 | Pharmaceutical compositions for the treatment of alzheimer's disease |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU1790988A (en) |
| IL (1) | IL86423A0 (en) |
| WO (1) | WO1988009171A1 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6693076B1 (en) | 1989-06-05 | 2004-02-17 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factors and analogs |
| US5652214A (en) * | 1989-06-05 | 1997-07-29 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factors and analogs |
| US6723699B1 (en) | 1989-06-05 | 2004-04-20 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factors and analogs |
| US6407061B1 (en) | 1989-12-05 | 2002-06-18 | Chiron Corporation | Method for administering insulin-like growth factor to the brain |
| US5624898A (en) | 1989-12-05 | 1997-04-29 | Ramsey Foundation | Method for administering neurologic agents to the brain |
| US5760021A (en) * | 1992-05-29 | 1998-06-02 | The Procter & Gamble Company | Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| JP3666818B2 (en) * | 1993-03-29 | 2005-06-29 | クイーンズ ユニバーシティ アット キングストン | Treatment of amyloidosis |
| US20040208875A1 (en) | 1995-03-15 | 2004-10-21 | Queen's University At Kingston | Method for treating amyloidosis |
| US6008188A (en) * | 1994-05-06 | 1999-12-28 | Kanebo Limited | Cytokine potentiator and pharmaceutical formulation for cytokine administration |
| CN1265588A (en) * | 1997-07-28 | 2000-09-06 | 理化学研究所 | Protecting and survival promoting agent for central nervous cell |
| US7273618B2 (en) | 1998-12-09 | 2007-09-25 | Chiron Corporation | Method for administering agents to the central nervous system |
| IL131334A0 (en) * | 1999-08-10 | 2001-01-28 | Yeda Res & Dev | Pharmaceutical compositions comprising hydroxyamines |
| US7226916B1 (en) | 2000-05-08 | 2007-06-05 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
| US7115585B2 (en) * | 2000-08-21 | 2006-10-03 | Inspire Pharmaceuticals, Inc. | Compositions for treating epithelial and retinal tissue diseases |
| WO2002094856A2 (en) | 2001-05-24 | 2002-11-28 | Neuronz Limited | Gpe analogs and peptidomimetics |
| US7714020B2 (en) | 2001-05-24 | 2010-05-11 | Neuren Pharmaceuticals Limited | Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate |
| US7605177B2 (en) | 2001-05-24 | 2009-10-20 | Neuren Pharmaceuticals Limited | Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration |
| US8044100B2 (en) | 2004-12-22 | 2011-10-25 | Bellus Health Inc. | Methods and compositions for treating amyloid-related diseases |
| WO2007125385A2 (en) | 2005-12-22 | 2007-11-08 | Neurochem (International) Limited | Treatment of renal disorders, diabetic nephopathy and dyslipidemias |
| EP3851447B1 (en) | 2006-10-12 | 2023-09-06 | Bellus Health Inc. | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| CN114099487A (en) * | 2021-12-22 | 2022-03-01 | 上海市第一人民医院 | Application of ethanolamine in preparation of product for preventing, relieving and/or treating neuroinflammation related diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2437834A1 (en) * | 1978-10-04 | 1980-04-30 | Lejeune Jerome | L-serine or glycine for treatment of cerebral deficiencies - such as mongolism and general mental debility, etc. |
| US4569929A (en) * | 1980-02-29 | 1986-02-11 | Massachusetts Institute Of Technology | Cytidyl diphosphocholine-drug composition |
| US4386078A (en) * | 1980-03-03 | 1983-05-31 | The Ohio State University Research Foundation | Therapeutic agents for preventing phospholipid degradation and free fatty acid proliferation |
-
1988
- 1988-05-18 IL IL86423A patent/IL86423A0/en unknown
- 1988-05-18 AU AU17909/88A patent/AU1790988A/en not_active Abandoned
- 1988-05-18 WO PCT/US1988/001693 patent/WO1988009171A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1988009171A1 (en) | 1988-12-01 |
| AU1790988A (en) | 1988-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL86423A0 (en) | Pharmaceutical compositions for the treatment of alzheimer's disease | |
| ZA829335B (en) | Pharmaceutical preparation for treating alzheimer's disease | |
| EP0541686A4 (en) | Tachykinin agonists for treatment of alzheimer's disease | |
| EP0243002A3 (en) | Pharmaceutical composition for the treatment of periodontal diseases | |
| GB2188844B (en) | Pharmaceutical composition for the treatment of psoriasis | |
| EP0331620A3 (en) | Agent for the treatment of parkinson's disease | |
| IL76561A (en) | Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases | |
| IL117695A0 (en) | Pharmaceutical agents for the treatment of alzheimer's disease | |
| ZA875847B (en) | Pharmaceutical compositions for the treatment of occlusive vascular diseases | |
| GB2204488B (en) | Pharmaceutical compositions for the treatment or prophylaxis of skin disorders | |
| IL104132A0 (en) | Compositions for the treatment of mammalian diseases | |
| EP0297296A3 (en) | Process for the preparation of 2,2'-oxybisûn,n-dimethyl-ethylamine¨ | |
| IL93242A0 (en) | Pharmaceutical preparation for the treatment of tonsillitis | |
| CS22891A2 (en) | Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases | |
| IL96455A0 (en) | Pharmaceutical compositions for the treatment of hsv | |
| IL94402A0 (en) | Pharmaceutical compositions containing imidazodiazepines for the treatment of neurological symptoms | |
| AP9000180A0 (en) | Pharmaceutical composition for the treatment of protozoal diseases | |
| ZA915462B (en) | Composition for the treatment of alzheimer's disease and process for preparing the same | |
| HUP0000570A3 (en) | Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
| GB8728036D0 (en) | Therapy for alzheimer's disease | |
| IL89431A0 (en) | Pharmaceutical compositions for the treatment of autoimmune diseases | |
| GB8709860D0 (en) | Pharmaceutical compositions & treatment | |
| GB8709862D0 (en) | Pharmaceutical compositions & treatment | |
| GB8709861D0 (en) | Pharmaceutical compositions & treatment | |
| GB8925512D0 (en) | Therapy for alzheimer's disease |